Our Pricing

Get Your Weight Loss Injection Today - Fast UK Access

Finding a trusted weight loss injection UK online pharmacy means accessing genuine MHRA-licensed treatments with proper clinical oversight. At Cured Pharmacy, our UK-registered prescribers assess your suitability for Mounjaro, Wegovy, or Saxenda in under 3 minutes, with discreet next-day delivery available across the UK.

How Weight Loss Injections Work in the UK

Weight loss injections approved in the UK work through GLP-1 (glucagon-like peptide-1) receptor pathways, mimicking natural hormones that regulate appetite and blood glucose [1]. These medications slow gastric emptying, increase satiety signals to the brain, and reduce hunger between meals, creating a sustainable calorie deficit without the constant willpower battle many patients experience with diet alone.

Mounjaro (tirzepatide) represents the latest advancement, acting on both GIP and GLP-1 receptors simultaneously. In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 20.9% over 72 weeks on the 15mg dose—substantially higher than earlier single-pathway treatments [1]. Wegovy (semaglutide) demonstrated average weight loss of 14.9% in the STEP 1 trial, while Saxenda (liraglutide) showed 8% average reduction in the SCALE trial [2][3].

All three medications are prescription-only in the UK and require ongoing clinical monitoring. Your prescriber will determine which treatment suits your medical history, BMI, and weight loss goals. Results vary between individuals, and these injections work best alongside reduced-calorie intake and increased physical activity.

Mounjaro Weight Loss Injections: UK Availability and Pricing

Mounjaro received MHRA approval for weight management in the UK in 2023, following extensive clinical trials demonstrating its efficacy in adults with obesity or overweight with weight-related comorbidities [1]. The medication comes in pre-filled KwikPen devices for once-weekly subcutaneous injection, typically administered in the abdomen, thigh, or upper arm.

Eligibility criteria mirror NICE guidance: BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidaemia. Your prescriber will verify your suitability during the online consultation, reviewing your medical history, current medications, and any contraindications before approving treatment.

What Makes Tirzepatide Different

Tirzepatide's dual-agonist mechanism targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors, producing greater metabolic effects than GLP-1-only treatments [1]. This dual action improves insulin sensitivity, reduces glucagon secretion more effectively, and appears to produce superior weight loss outcomes in head-to-head comparisons.

At Cured Pharmacy, Mounjaro is available from £135.00 per pen, with dosing typically starting at 2.5mg weekly and titrating upward every 4 weeks based on tolerance and response. All prescriptions require clinical assessment by our UK-registered prescribers, and pricing is transparent before you complete your consultation—no hidden fees or surprise charges at checkout.

Wegovy and Saxenda: Established Weight Loss Injection Options

Semaglutide's longer half-life allows weekly administration, which many patients find more convenient than daily injections. The medication is initiated at 0.25mg weekly, with gradual dose escalation over 16-20 weeks to the maintenance dose of 2.4mg [2]. This titration schedule minimises gastrointestinal side effects, the most common tolerability issue with GLP-1 therapies.

Liraglutide (Saxenda) is administered daily at doses up to 3mg, offering flexibility for patients who prefer smaller, more frequent dosing or who experience side effects with longer-acting formulations. Clinical experience shows some patients tolerate daily GLP-1 administration better than weekly bolus doses, though adherence can be more challenging with daily regimens [3].

Comparing Semaglutide and Liraglutide

Wegovy (semaglutide) offers once-weekly dosing with proven efficacy across multiple large-scale trials. The STEP programme enrolled over 4,500 participants, demonstrating sustained weight loss when combined with lifestyle intervention [2]. Saxenda (liraglutide) requires daily injection but has the longest real-world safety data, having been used for weight management since 2015.

Both medications are available at Cured Pharmacy with competitive UK pricing. Wegovy starts from £135.00, while Saxenda is available from £135.00. Your prescriber will consider factors like injection frequency preference, previous treatment response, and cost when recommending the most appropriate option for your circumstances.

Oral Weight Loss Treatments: Orlistat and Alternatives

Not all patients are suitable candidates for injectable treatments, and oral medications remain an important option for UK weight management. Orlistat works through a completely different mechanism—blocking pancreatic lipase enzymes to prevent approximately 30% of dietary fat absorption [4]. This leads to average weight loss of 3kg more than diet and exercise alone over 12 months.

Orlistat is available in prescription-strength 120mg capsules (Orlistat, Xenical) and lower-dose 60mg formulations available without prescription (Alli, Orlos). At Cured Pharmacy, prescription Orlistat starts from £135.00, with Xenical branded capsules from £135.00. The medication requires three times daily dosing with meals containing fat, and works best when dietary fat intake is distributed evenly throughout the day.

Gastrointestinal side effects are common with Orlistat, particularly if fat intake exceeds 30% of total calories. Patients experience reduced side effects when following a lower-fat eating plan. Unlike GLP-1 treatments, Orlistat does not suppress appetite hormonally—weight loss results purely from malabsorption of dietary fat. Your prescriber will discuss which approach aligns better with your eating patterns and lifestyle.

Clinical Assessment Process for Weight Loss Injection UK Prescriptions

All prescription weight loss medications in the UK require clinical oversight, whether obtained through your GP, a private clinic, or an online pharmacy like Cured. Our prescribers follow NICE guidelines and MHRA prescribing information when assessing suitability, ensuring the same clinical standards apply regardless of how you access treatment [5].

Ongoing monitoring is essential with GLP-1 therapies. Patients should report any persistent nausea, vomiting, abdominal pain, or signs of pancreatitis immediately. Regular weight and blood pressure monitoring helps track progress and identify any concerns early. Our clinical team is available by phone during business hours if you have questions about your treatment or experience unexpected side effects.

What to Expect During Your Online Consultation

Our online consultation takes under 3 minutes to complete and covers essential medical history including cardiovascular conditions, kidney function, previous weight loss attempts, current medications, and any history of pancreatitis or thyroid disorders. This information allows our UK-registered prescribers to assess contraindications and drug interactions safely.

If approved, your prescription is issued electronically and forwarded to our dispensary team. Medications are dispensed by GPhC-registered pharmacists and dispatched in discreet, unmarked packaging. Next-day delivery is available across the UK, with tracking provided for all orders. If your prescriber determines that weight loss injections are not appropriate for your circumstances, they will explain why and may suggest alternative approaches.

Maximising Results: Lifestyle Factors and Realistic Expectations

Weight loss typically occurs gradually over 6-12 months, with most patients losing 1-2kg per month on average. Rapid initial losses in the first 8-12 weeks often include water weight and glycogen depletion. Sustainable fat loss requires patience and consistency—crash dieting or excessive calorie restriction can trigger metabolic adaptation and muscle loss.

Plateaus are normal and expected. If weight loss stalls after initial progress, your prescriber may adjust your dose, review your dietary intake, or suggest modifications to your exercise routine. Some patients reach their goal weight and discontinue treatment, while others require ongoing medication to maintain losses. Discontinuation should always be discussed with your prescriber, as weight regain is common when medication is stopped without a solid maintenance plan in place [6].

Combining Medication with Sustainable Habit Changes

Clinical trials of weight loss injections included structured lifestyle interventions—typically 500-calorie daily deficit and 150 minutes of moderate physical activity weekly [1][2]. Real-world results depend heavily on maintaining these behavioural changes alongside medication. Injections reduce hunger and make calorie restriction more tolerable, but they are not a substitute for dietary modification.

Patients who view these medications as tools to support behaviour change, rather than standalone solutions, achieve better long-term outcomes. Focus on protein intake to preserve lean muscle mass during weight loss, prioritise whole foods over processed options, and establish consistent eating patterns that you can maintain after treatment ends.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
4. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155
5. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875
6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to lifestyle modifications alongside medication use.